68 results on '"Gustafsson, F."'
Search Results
2. Defining Optimal Criteria for LVAD Weaning in HF Patients with an Improvement in Cardiac Structure and Function: A VAD Wean Registry Analysis
3. The Role of Cardiopulmonary Exercise Testing for Predicting Outcomes After LVAD Weaning, a VAD Wean Registry Study
4. The Effect of Everolimus vs Calcineurin Inhibitors on Quality of Life 11 Years After Heart Transplantation: The Results of a Randomized Controlled Trial (Schedule Trial)
5. Impact of Hemolysis During Micro-Axial Flow Pump Support on Early Outcomes After Durable LVAD Implantation: Insights from an International Registry
6. Impact of Stroke After Durable LVAD Implantation in Patients Bridged with Micro-Axial Flow Pump: Insights from an International Registry
7. (340) Prognostic Value of Repeated Peak Oxygen Uptake Measurements in LVAD Patients - Follow Up on PRO-VAD Study
8. (1056) Use of Induction Therapy Post Heart Transplantation - Clinical Practice Recommendations Based on Systematic Review and Network Meta-Analysis of Evidence
9. (766) Improvement in Peak Oxygen Uptake During First Year of Mechanical Circulatory Support in End-Stage Heart Failure Patients - Follow Up on PRO-VAD Study
10. A Multi-Center Evaluation of Outflow Graft Obstruction with a Fully Magnetically Levitated Left Ventricular Assist Device
11. Use of Induction Therapy Post Heart Transplantation: A Heart Transplant Rapid Recommendations
12. Outcomes after Cardiovascular Implantable Electronic Device Pulse Generator Replacement in Patients with Durable Left Ventricular Assist Devices
13. Use of Prednisone Increases Post Heart Transplantation Mortality: Is it a Necessary Evil?
14. Patients with Fulminant Myocarditis Supported with Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis of Short-Term Mortality and Impact of Risk Factors
15. Iron Deficiency in Left Ventricular Assist Device Recipients
16. Early IVUS-Guided Selection for Non-Invasive Cardiac Allograft Vasculopathy (CAV) Screening in Heart Transplant Recipients
17. Effect of High-Intensity Interval Training on Progression of Coronary Artery Vasculopathy in De Novo Heart Transplant Recipients
18. Atrial Fibrillation is a Predictor of Poor Physical Capacity 6 Months after Implantation of a Full Magnetically Levitated Left Ventricular Assist Device: An Analysis from ELEVATE
19. Two-Year Outcomes in Real World Patients Treated with Heartmate 3TM Left Ventricular Assist Device for Advanced Heart Failure: Data from the ELEVATE Registry
20. EVOLVD: Cholesterol Lowering with EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-Novo Heart Transplant Recipients: Rationale and Design of a Randomized, Controlled Trial
21. Regional Outcomes after Continuous-Flow Left Ventricular Assist Device: An IMACS Analysis
22. Association between Serial Measurements of Tricuspid Annular Plane Systolic Excursion and Mortality Post Heart Transplant
23. Mild Acute Cellular Rejection is Not Associated with Development of Cardiac Allograft Vasculopathy Assessed by Intravascular Ultrasound and Coronary Angiography in Heart Transplant Recipients - A Substudy of the SCHEDULE Trial
24. The Significance of NT-proBNP in Patients Assessed for Heart Transplant or LVAD
25. Effect of Heart Rate Reserve on Exercise Capacity in Patients Treated With a Continuous Flow Left Ventricular Assist Device: A Multicentre Study
26. The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy in De-Novo Heart Transplant Recipients: Results of the Schedule Trial after 6 Years
27. The Effect of Everolimus vs Calcineurin Inhibitors on Quality of Life During 5-6 Years Follow-up After Heart Transplantation: The Results of a Randomized Controlled Trial (SCHEDULE)
28. Right Atrial and Ventricular Ejection Fractions at Rest Measured by Cardiac CT Predict Right Heart Function During Exercise But Do Not Determine Exercise Capacity in LVAD Recipients
29. Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients - 1 Year Follow Up (The HITTS Study)
30. The Effect of Everolimus vs Calcineurin Inhibitors on Left Ventricular Mass in De Novo Heart Transplant Recipients After 3 Years Follow-Up - Results From the Randomized Controlled SCHEDULE Trial
31. Clinical Outcomes with Heartmate 3 TM Left Ventricular Assist Device as Treatment for Advanced Heart Failure: 12-Month Outcomes from the ELEVATE Registry
32. Clinical Outcomes with Heartmate 3 as Treatment for Advanced HF: First Data from the European ELEVATE Registry
33. Pump Speed Increase Improves Submaximal Exercise Tolerance in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients-A Double Blind Randomized Trial
34. The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy Assessed by Virtual Histology: Results of the SCHEDULE Trial
35. Long-term Effect on Albuminuria and Glomerular Filtration Rate of a Calcineurin Inhibitor-Free Everolimus Based Immunosuppressive Regimen after Heart Transplantation
36. Three Year Follow Up of the Randomized SCHEDULE Trial With Everolimus Initiation and Early Withdrawal of Calcineurin Inhibitor Therapy in De Novo Heart Transplant Recipients - A Multicenter, Randomized Scandinavian Trial
37. The Effect of Everolimus vs. Calcineurin Inhibitors on Surgical Complications: The Results of a De Novo Heart Transplant Randomized Controlled Trial (SCHEDULE Trial)
38. The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy in De-Novo Heart Transplant: Recipients: Results of the SCHEDULE Trial After 36 Months
39. Long Term Outcomes in Thoracic Transplant Recipients After Conversion to Everolimus With Reduced Calcineurin Inhibitor Within a Multicenter, Open-Label, Randomized Trial
40. The Effect of Everolimus Initiation and Calcineurin Inhibitor Reduction on Allograft Vasculopathy in Maintenance Heart Transplant Recipients: Results of the NOCTET Trial After 5 Years
41. Acute Blood Pressure Adaptations During Heavy Resistance Exercise in Patients With Heart Failure and Transplant Recipients: A Clinical Investigation Using Continued Blood Pressure Surveillance
42. The Effect of Everolimus vs. Calcineurin Inhibitors on Quality of Life During 3 Years Follow Up: The Result of a Randomized Controlled Trial (SCHEDULE Trial)
43. Postcapillary Pulmonary Hypertension as a Risk Factor for Post-Transplant Survival in Lung Transplantation - A 22 Year Single Centre Experience
44. A CNI-Free, Everolimus Based Regimen in De-Novo Heart Transplant Recipients Increases Albuminuria But Improves Glomerular Filtration Rate Compared With Conventional Immunosuppression
45. Everolimus and Cyclosporine Equally Improve QoL in De Novo Heart Transplanted Patients: The Results of a Randomized Controlled Trial (SCHEDULE Trial)
46. Increasing Pump Speed During Exercise Improves Peak Oxygen Consumption in Heart Failure Patients Supported With Continuous-Flow Left Ventricular Assist Devices - A Double-Blind Randomized Study
47. Pressure-Volume Relations in Patients Supported With Continuous-Flow Left Ventricular Assist Devices: A Comparative Descriptive Study of Invasive Hemodynamics Versus Echocardiography
48. Percutaneous Implantation of a Novel Interatrial Shunt Device in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction: Initial Results of a Pilot Trial
49. Everolimus Initiation With Calcineurin Inhibitor Withdrawal Reduces Allograft Vasculopathy in De-Novo Heart Transplant Recipients
50. Long-Term Outcomes of Left Ventricular Asisst Device Therapy in Scandinavia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.